UPSIDE Foods, a Berkeley, California-based company that grows meat, poultry and seafood directly from animal cells, becomes the first in the world to receive approval from the U.S. Food and Drug Administration for its lab-grown meat. The FDA said that its meat product is safe for human consumption.
According to Reuters, this is the first time that the U.S. FDA has granted such approval for cultivated meat. The US agency revealed its decision on Wednesday this week. UPSIDE Foods made chicken meat by collecting cells from live animals and using them to cultivate meat inside stainless steel tanks.
With the FDA’s approval, the company may continue with its plans to sell its products. However, in a joint statement, Robert M. Califf, M.D., the commissioner of Food and Drugs - Food and Drug Administration and Susan T. Mayne, Ph.D., the director of Center for Food Safety and Applied Nutrition (CFSAN), said that before UPSIDE Foods can fully proceed with marketing the cell-cultured meat, an inspection from the U.S. Department of Agriculture (USDA) and USDA-Food Safety and Inspection Service (FSIS) are still needed.
At any rate, the American food and drug regulator further said that it had already analyzed data from UPSIDE Foods, and it has no further questions about its conclusion that the lab-grown meat is safe to eat. But then again, the FDA explained that its review is not technically an approval and pointed out that it is only for UPSIDE products and does not apply to other companies in the same business.
"This is a watershed moment in the history of food and we started UPSIDE amid a world full of skeptics, and today, we've made history again as the first company to receive a 'No Questions' letter from the FDA for cultivated meat,” UPSIDE Foods’ founder and chief executive officer, Dr. Uma Valeti, said in a press release.
The CEO added, “This milestone marks a major step towards a new era in meat production, and I'm thrilled that U.S. consumers will soon have the chance to eat delicious meat that's grown directly from animal cells."


Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
China Extends Gold Buying Streak as Reserves Surge Despite Volatile Prices
Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Japan Economy Poised for Q4 2025 Growth as Investment and Consumption Hold Firm
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
India–U.S. Interim Trade Pact Cuts Auto Tariffs but Leaves Tesla Out
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 



